Logo image of OXLCN

OXFORD LANE CAPITAL CORP - OXLC 7 1/8 06/30/29 (OXLCN) Stock Fundamental Analysis

NASDAQ:OXLCN - Nasdaq - US6915438708 - Currency: USD

23.97  -0.05 (-0.23%)

After market: 24.01 +0.04 (+0.17%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to OXLCN. OXLCN was compared to 0 industry peers in the Unkown industry. OXLCN may be in some trouble as it scores bad on both profitability and health. OXLCN shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

OXLCN had positive earnings in the past year.
OXLCN had a negative operating cash flow in the past year.
In multiple years OXLCN reported negative net income over the last 5 years.
OXLCN had a negative operating cash flow in each of the past 5 years.
OXLCN Yearly Net Income VS EBIT VS OCF VS FCFOXLCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

Industry RankSector Rank
ROA 8.32%
ROE 11.55%
ROIC 8.27%
ROA(3y)3.18%
ROA(5y)-2.83%
ROE(3y)3.92%
ROE(5y)-9.58%
ROIC(3y)9.45%
ROIC(5y)9.55%
OXLCN Yearly ROA, ROE, ROICOXLCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

OXLCN's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of OXLCN has grown nicely.
In the last couple of years the Gross Margin of OXLCN has grown nicely.
Industry RankSector Rank
OM 62.46%
PM (TTM) 51.99%
GM 64.82%
OM growth 3Y0.43%
OM growth 5Y2.05%
PM growth 3Y-30.44%
PM growth 5YN/A
GM growth 3Y0.99%
GM growth 5Y2.29%
OXLCN Yearly Profit, Operating, Gross MarginsOXLCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

3

2. Health

2.1 Basic Checks

The number of shares outstanding for OXLCN has been increased compared to 1 year ago.
Compared to 5 years ago, OXLCN has more shares outstanding
The debt/assets ratio for OXLCN is higher compared to a year ago.
OXLCN Yearly Shares OutstandingOXLCN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
OXLCN Yearly Total Debt VS Total AssetsOXLCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 10.39 indicates that OXLCN is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.33 indicates that OXLCN is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z 10.39
ROIC/WACCN/A
WACCN/A
OXLCN Yearly LT Debt VS Equity VS FCFOXLCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

OXLCN has a Current Ratio of 2.29. This indicates that OXLCN is financially healthy and has no problem in meeting its short term obligations.
OXLCN has a Quick Ratio of 2.29. This indicates that OXLCN is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.29
Quick Ratio 2.29
OXLCN Yearly Current Assets VS Current LiabilitesOXLCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

OXLCN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.77%, which is quite impressive.
The Earnings Per Share has been growing slightly by 1.01% on average over the past years.
The Revenue has grown by 27.85% in the past year. This is a very strong growth!
OXLCN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.97% yearly.
EPS 1Y (TTM)39.77%
EPS 3Y-30.19%
EPS 5Y1.01%
EPS Q2Q%-12.62%
Revenue 1Y (TTM)27.85%
Revenue growth 3Y34.07%
Revenue growth 5Y27.97%
Sales Q2Q%34.46%

3.2 Future

Based on estimates for the next years, OXLCN will show a decrease in Earnings Per Share. The EPS will decrease by -4.49% on average per year.
OXLCN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 44.23% yearly.
EPS Next Y5.32%
EPS Next 2Y-4.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year42.59%
Revenue Next 2Y44.23%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OXLCN Yearly Revenue VS EstimatesOXLCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
OXLCN Yearly EPS VS EstimatesOXLCN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 1.5

1

4. Valuation

4.1 Price/Earnings Ratio

OXLCN is valuated rather expensively with a Price/Earnings ratio of 19.49.
The average S&P500 Price/Earnings ratio is at 25.25. OXLCN is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 21.36, which indicates a rather expensive current valuation of OXLCN.
When comparing the Price/Forward Earnings ratio of OXLCN to the average of the S&P500 Index (21.27), we can say OXLCN is valued inline with the index average.
Industry RankSector Rank
PE 19.49
Fwd PE 21.36
OXLCN Price Earnings VS Forward Price EarningsOXLCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OXLCN Per share dataOXLCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A cheap valuation may be justified as OXLCN's earnings are expected to decrease with -4.49% in the coming years.
PEG (NY)3.67
PEG (5Y)19.39
EPS Next 2Y-4.49%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 19.59%, OXLCN is a good candidate for dividend investing.
OXLCN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 19.59%

5.2 History

The dividend of OXLCN decreases each year by -11.84%.
OXLCN has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)-11.84%
Div Incr Years1
Div Non Decr Years2
OXLCN Yearly Dividends per shareOXLCN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

OXLCN pays out 118.16% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of OXLCN has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP118.16%
EPS Next 2Y-4.49%
EPS Next 3YN/A
OXLCN Yearly Income VS Free CF VS DividendOXLCN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
OXLCN Dividend Payout.OXLCN Dividend Payout, showing the Payout Ratio.OXLCN Dividend Payout.PayoutRetained Earnings

OXFORD LANE CAPITAL CORP - OXLC 7 1/8 06/30/29

NASDAQ:OXLCN (5/16/2025, 8:12:25 PM)

After market: 24.01 +0.04 (+0.17%)

23.97

-0.05 (-0.23%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-12 2025-05-12/bmo
Earnings (Next)07-24 2025-07-24
Inst Owners4.72%
Inst Owner ChangeN/A
Ins Owners4.53%
Ins Owner ChangeN/A
Market Cap10.48B
Analysts85
Price Target27.88 (16.31%)
Short Float %0%
Short Ratio1.7
Dividend
Industry RankSector Rank
Dividend Yield 19.59%
Yearly Dividend0.81
Dividend Growth(5Y)-11.84%
DP118.16%
Div Incr Years1
Div Non Decr Years2
Ex-Date05-16 2025-05-16 (0.1484375)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.44%
PT rev (3m)-0.05%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.55%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.5%
Valuation
Industry RankSector Rank
PE 19.49
Fwd PE 21.36
P/S 29.38
P/FCF N/A
P/OCF N/A
P/B 6.53
P/tB 6.53
EV/EBITDA N/A
EPS(TTM)1.23
EY5.13%
EPS(NY)1.12
Fwd EY4.68%
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.65
OCFYN/A
SpS0.82
BVpS3.67
TBVpS3.67
PEG (NY)3.67
PEG (5Y)19.39
Profitability
Industry RankSector Rank
ROA 8.32%
ROE 11.55%
ROCE 10.47%
ROIC 8.27%
ROICexc 9.16%
ROICexgc 9.16%
OM 62.46%
PM (TTM) 51.99%
GM 64.82%
FCFM N/A
ROA(3y)3.18%
ROA(5y)-2.83%
ROE(3y)3.92%
ROE(5y)-9.58%
ROIC(3y)9.45%
ROIC(5y)9.55%
ROICexc(3y)9.69%
ROICexc(5y)9.95%
ROICexgc(3y)9.7%
ROICexgc(5y)9.96%
ROCE(3y)11.96%
ROCE(5y)12.09%
ROICexcg growth 3Y2.9%
ROICexcg growth 5Y2.67%
ROICexc growth 3Y2.77%
ROICexc growth 5Y2.8%
OM growth 3Y0.43%
OM growth 5Y2.05%
PM growth 3Y-30.44%
PM growth 5YN/A
GM growth 3Y0.99%
GM growth 5Y2.29%
F-Score4
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 7.06
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.29
Quick Ratio 2.29
Altman-Z 10.39
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.77%
EPS 3Y-30.19%
EPS 5Y1.01%
EPS Q2Q%-12.62%
EPS Next Y5.32%
EPS Next 2Y-4.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)27.85%
Revenue growth 3Y34.07%
Revenue growth 5Y27.97%
Sales Q2Q%34.46%
Revenue Next Year42.59%
Revenue Next 2Y44.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.53%
EBIT growth 3Y34.65%
EBIT growth 5Y30.6%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y18.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.28%
OCF growth 3YN/A
OCF growth 5YN/A